We are live on ! Find out more
PROK icon

ProKidney
PROK

18 hedge funds and large institutions have $144M invested in ProKidney in 2022 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 60 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

23% less capital invested

Capital invested by funds: $187M → $144M (-$42.5M)

48.87% less ownership

Funds ownership: 74.91% → 26.04% (-49%)

73% less funds holding

Funds holding: 67 → 18 (-49)

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

80% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 60

Holders
18
Holders Change
-49
Holders Change %
-73.13%
% of All Funds
0.31%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
1
Reduced
4
Closed
60
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$90.1M
2
SCM
Suvretta Capital Management
New York
+$27.8M
3
BL
Bleichroeder LP
New York
+$17.4M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.32M
5
BlackRock
BlackRock
New York
+$947K

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$17.4M
2
Millennium Management
Millennium Management
New York
-$14.8M
3
ACA
Arena Capital Advisors
California
-$11.7M
4
SC
Sculptor Capital
New York
-$11.1M
5
FTCM
First Trust Capital Management
Illinois
-$8.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
51
Jane Street
New York
– -$1.49M -150,007 Closed
KPF
52
K2 Principal Fund
Ontario, Canada
– -$1.37M -136,937 Closed
FTCM
53
Fir Tree Capital Management
New York
– -$1.37M -136,899 Closed
RCM
54
Radcliffe Capital Management
Pennsylvania
– -$1.24M -125,000 Closed
CPM
55
Crescent Park Management
California
– -$1.23M -123,213 Closed
PSAMP
56
P. Schoenfeld Asset Management (PSAM)
New York
– -$1.22M -122,379 Closed
AGC
57
Angelo Gordon & Co
New York
– -$1M -100,000 Closed
DCM
58
Dupont Capital Management
Delaware
– -$995K -100,000 Closed
JP Morgan Chase
59
JP Morgan Chase
New York
– -$995K -100,000 Closed
PMAM
60
Picton Mahoney Asset Management
Ontario, Canada
– -$1M -100,000 Closed
TCM
61
Tenor Capital Management
New York
– -$746K -75,000 Closed
E
62
Ergoteles
New York
– -$627K -62,981 Closed
SIM
63
Sandia Investment Management
Massachusetts
– -$498K -50,000 Closed
SCM
64
Shaolin Capital Management
Florida
– -$498K -50,000 Closed
Walleye Trading
65
Walleye Trading
New York
– -$484K -48,600 Closed
WRBC
66
W.R. Berkley Corp
Connecticut
– -$482K -48,399 Closed
Goldman Sachs
67
Goldman Sachs
New York
– -$432K -43,400 Closed
SSA
68
Schonfeld Strategic Advisors
New York
– -$426K -42,852 Closed
MC
69
Meteora Capital
Florida
– -$421K -42,299 Closed
Bank of Nova Scotia
70
Bank of Nova Scotia
Ontario, Canada
– -$398K -40,000 Closed
CAC
71
Cowen and Company
New York
– -$381K -38,248 Closed
BFM
72
Boothbay Fund Management
New York
– -$203K -20,448 Closed
CS
73
Clear Street
New York
– -$199K -20,000 Closed
Walleye Capital
74
Walleye Capital
New York
– -$134K -13,500 Closed
CCM
75
Condor Capital Management
New Jersey
– -$98K -9,870 Closed
1 2
3
4

PROK Hedge Fund Activity: Q3 2022 in Review

18 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in ProKidney (PROK) for Q3 2022, worth a combined $144M — down 23% from $187M a quarter earlier.

Sellers outnumbered buyers: 60 funds closed out of PROK and 12 opened new positions — a net loss of 48 holders — while 4 trimmed existing stakes and 1 added.

The largest buyer was Morgan Stanley, opening a new position worth an estimated $90.1M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $17.4M sold.

  • 18 institutional investors held ProKidney (PROK) as of Q3 2022, down from 67 in Q2 2022.
  • Funds reported $144M of ProKidney stock for Q3 2022, down 23% quarter-over-quarter.
  • 12 funds opened new ProKidney positions in Q3 2022 and 60 closed out, a net change of -48 holders.
  • The largest ProKidney buyer in Q3 2022 was Morgan Stanley, an estimated $90.1M added.
  • The largest ProKidney seller in Q3 2022 was Adage Capital Partners, an estimated $17.4M sold.

Based on aggregated 13F filings for Q3 2022.